Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age-Reference-Cited by-同舟云学术

Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

Published:2022-02-04 Issue:3 Volume:33 Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Reviews in Medical Virology

Author:

Comber Laura¹^ORCID,O Murchu Eamon¹²,Jordan Karen¹^ORCID,Hawkshaw Sarah¹,Marshall Liam¹,O'Neill Michelle¹,Teljeur Conor¹,Ryan Máirín¹³,Carnahan AnnaSara⁴⁵,Pérez Martín Jaime Jesús⁴⁶,Robertson Anna Hayman⁴⁷,Johansen Kari⁴⁸,de Jonge Jorgen⁴⁹,Krause Tyra⁴¹⁰,Nicolay Nathalie⁴⁸,Nohynek Hanna⁴¹¹,Pavlopoulou Ioanna⁴¹²¹³,Pebody Richard⁴¹⁴,Penttinen Pasi⁴⁸,Soler‐Soneira Marta⁴¹⁵,Wichmann Ole⁴¹⁶,Harrington Patricia¹

Affiliation:

1. Health Information and Quality Authority (HIQA) Dublin Ireland

2. Department of Health Policy & Management School of Medicine Trinity College Dublin Dublin Ireland

3. Department of Pharmacology & Therapeutics Trinity College Dublin Trinity Health Sciences Dublin Ireland

4. European Centre for Disease Prevention and Control EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines Solna Sweden

5. Public Health Agency of Sweden Solna Sweden

6. General Directorate of Public Health and Addictions IMIB‐Arrixaca Murcia University Region of Murcia Spain

7. Division of Infection Control and Environmental Health Norwegian Institute of Public Health Oslo Norway

8. European Centre for Disease Prevention and Control Stockholm Sweden

9. National Institute for Public Health and the Environment Center for Infectious Disease Control Bilthoven The Netherlands

10. Statens Serum Institut Copenhagen Denmark

11. Finnish Institute for Health and Welfare Helsinki Finland

12. Pediatric Research Laboratory School of Health Sciences Faculty of Nursing National & Kapodistrian University of Athens Goudi Greece

13. National Advisory Committee on Immunisation Hellenic Ministry of Health Athens Greece

14. Institute of Epidemiology & Health University College London London UK

15. Vigilancia de Enfermedades Prevenibles por Vacunación Centro Nacional de Epidemiología Instituto de Salud Carlos III Ministerio de Ciencia e Innovación Madrid Spain

16. Immunization Unit Robert Koch‐Institute Berlin Germany

Funder

European Centre for Disease Prevention and Control

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2330

Reference81 articles.

1. Universal influenza vaccines: Shifting to better vaccines

2. European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?

3. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study;Vaccines;2024-09-10

2. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine;Drugs;2024-08-21

3. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19

4. Estimates of Seasonal Influenza Burden That Could Be Averted by Improved Influenza Vaccines in the Australian Population Aged Under 65 Years, 2015–2019;Influenza and Other Respiratory Viruses;2024-04

5. Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses;2024-03-29